128
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Autoimmune enteropathy in Swedish children, 1985–2002: A call for strict diagnostic criteria

, MD, &
Pages 1102-1107 | Received 15 Jan 2008, Published online: 08 Jul 2009
 

Abstract

Objective. To investigate the incidence, prevalence and the long-term outcome of autoimmune enteropathy in Sweden. Material and methods. In 2002 a questionnaire was sent to all paediatric departments in Sweden asking them to report all known cases of this condition from the period 1985–2002. Results. The response rate was 92%. Five patients were reported and 3 were included in the study. Only one patient fulfilled all the diagnostic criteria and two were considered as possible cases of autoimmune enteropathy. The incidence was 0.06 to 0.12×10−5 and the prevalence was 0.05 to 0.10×10−5 for children aged 0–16 years. At the end of the study period all 3 patients were still alive. Two boys were receiving immunosuppressive treatment and one girl was in remission and functioning well on a gluten-free diet only. One of the patients had adrenalitis. This combination has not been reported previously in autoimmune enteropathy. Conclusions. Autoimmune enteropathy in its severe forms is a rare disease in Sweden. None of the patients reported died during the study period. Comparative studies are difficult as different diagnostic criteria are used to diagnose this disease.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.